In fact, impaired OXPHOS and mitochondrial function in primary chronic lymphocytic leukemia (CLL), and Richter syndrome cultures and mouse models treated with a preclinical grade NFkB inhibitor correlated with reduced nuclear accumulation of p65 [142]. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.